Literature DB >> 19416848

Sanfilippo syndrome type B, a lysosomal storage disease, is also a tauopathy.

Kazuhiro Ohmi1, Lili C Kudo, Sergey Ryazantsev, Hui-Zhi Zhao, Stanislav L Karsten, Elizabeth F Neufeld.   

Abstract

Sanfilippo syndrome type B (mucopolysaccharidosis III B, MPS III B) is an autosomal recessive, neurodegenerative disease of children, characterized by profound mental retardation and dementia. The primary cause is mutation in the NAGLU gene, resulting in deficiency of alpha-N-acetylglucosaminidase and lysosomal accumulation of heparan sulfate. In the mouse model of MPS III B, neurons and microglia display the characteristic vacuolation of lysosomal storage of undegraded substrate, but neurons in the medial entorhinal cortex (MEC) display accumulation of several additional substances. We used whole genome microarray analysis to examine differential gene expression in MEC neurons isolated by laser capture microdissection from Naglu(-/-) and Naglu(+/-) mice. Neurons from the lateral entorhinal cortex (LEC) were used as tissue controls. The highest increase in gene expression (6- to 7-fold between mutant and control) in MEC and LEC neurons was that of Lyzs, which encodes lysozyme, but accumulation of lysozyme protein was seen in MEC neurons only. Because of a report that lysozyme induced the formation of hyperphosphorylated tau (P-tau) in cultured neurons, we searched for P-tau by immunohistochemistry. P-tau was found in MEC of Naglu(-/-) mice, in the same neurons as lysozyme. In older mutant mice, it was also seen in the dentate gyrus, an area important for memory. Electron microscopy of dentate gyrus neurons showed cytoplasmic inclusions of paired helical filaments, P-tau aggregates characteristic of tauopathies-a group of age-related dementias that include Alzheimer disease. Our findings indicate that the Sanfilippo syndrome type B should also be considered a tauopathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19416848      PMCID: PMC2677546          DOI: 10.1073/pnas.0903223106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Accumulation of intracellular amyloid-beta peptide (A beta 1-40) in mucopolysaccharidosis brains.

Authors:  S D Ginsberg; J E Galvin; V M Lee; L B Rorke; D W Dickson; J H Wolfe; M Z Jones; J Q Trojanowski
Journal:  J Neuropathol Exp Neurol       Date:  1999-08       Impact factor: 3.685

Review 2.  Antimicrobial polypeptides.

Authors:  Tomas Ganz
Journal:  J Leukoc Biol       Date:  2003-07-15       Impact factor: 4.962

3.  Global analysis of gene expression in neural progenitors reveals specific cell-cycle, signaling, and metabolic networks.

Authors:  Stanislav L Karsten; Lili C Kudo; Robert Jackson; Chiara Sabatti; Harley I Kornblum; Daniel H Geschwind
Journal:  Dev Biol       Date:  2003-09-01       Impact factor: 3.582

Review 4.  Staging of Alzheimer's disease-related neurofibrillary changes.

Authors:  H Braak; E Braak
Journal:  Neurobiol Aging       Date:  1995 May-Jun       Impact factor: 4.673

Review 5.  Management of mucopolysaccharidosis type III.

Authors:  M A Cleary; J E Wraith
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

6.  Neurofibrillary tangles in Niemann-Pick disease type C.

Authors:  S Love; L R Bridges; C P Case
Journal:  Brain       Date:  1995-02       Impact factor: 13.501

7.  Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation.

Authors:  Q Zheng-Fischhöfer; J Biernat; E M Mandelkow; S Illenberger; R Godemann; E Mandelkow
Journal:  Eur J Biochem       Date:  1998-03-15

8.  Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum.

Authors:  Arnaud Cressant; Nathalie Desmaris; Lucie Verot; Thomas Bréjot; Roseline Froissart; Marie-T Vanier; Irène Maire; Jean Michel Heard
Journal:  J Neurosci       Date:  2004-11-10       Impact factor: 6.167

9.  Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders.

Authors:  Robert McGlynn; Kostantin Dobrenis; Steven U Walkley
Journal:  J Comp Neurol       Date:  2004-12-20       Impact factor: 3.215

Review 10.  Staging of Alzheimer-related cortical destruction.

Authors:  H Braak; E Braak; J Bohl
Journal:  Eur Neurol       Date:  1993       Impact factor: 1.710

View more
  64 in total

Review 1.  Pathophysiology of neuropathic lysosomal storage disorders.

Authors:  Cinzia Maria Bellettato; Maurizio Scarpa
Journal:  J Inherit Metab Dis       Date:  2010-04-29       Impact factor: 4.982

2.  Storage vesicles in neurons are related to Golgi complex alterations in mucopolysaccharidosis IIIB.

Authors:  Sandrine Vitry; Julie Bruyère; Michaël Hocquemiller; Stéphanie Bigou; Jérôme Ausseil; Marie-Anne Colle; Marie-Christine Prévost; Jean Michel Heard
Journal:  Am J Pathol       Date:  2010-10-29       Impact factor: 4.307

3.  A Prospective Natural History Study of Mucopolysaccharidosis Type IIIA.

Authors:  Elsa G Shapiro; Igor Nestrasil; Kathleen A Delaney; Kyle Rudser; Victor Kovac; Nitin Nair; Charles W Richard; Patrick Haslett; Chester B Whitley
Journal:  J Pediatr       Date:  2016-01-16       Impact factor: 4.406

4.  Therapeutic efficacy of bone marrow transplant, intracranial AAV-mediated gene therapy, or both in the mouse model of MPS IIIB.

Authors:  Coy D Heldermon; Kevin K Ohlemiller; Erik D Herzog; Carole Vogler; Elizabeth Qin; David F Wozniak; Yun Tan; John L Orrock; Mark S Sands
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

5.  Near-Complete Correction of Profound Metabolomic Impairments Corresponding to Functional Benefit in MPS IIIB Mice after IV rAAV9-hNAGLU Gene Delivery.

Authors:  Haiyan Fu; Aaron S Meadows; Tierra Ware; Robert P Mohney; Douglas M McCarty
Journal:  Mol Ther       Date:  2017-01-28       Impact factor: 11.454

Review 6.  Lysosome trafficking and signaling in health and neurodegenerative diseases.

Authors:  Pearl P Y Lie; Ralph A Nixon
Journal:  Neurobiol Dis       Date:  2018-05-30       Impact factor: 5.996

7.  Beyond Krabbe's disease: The potential contribution of galactosylceramidase deficiency to neuronal vulnerability in late-onset synucleinopathies.

Authors:  Michael S Marshall; Ernesto R Bongarzone
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

8.  Toll-like receptor mediated lysozyme expression in Niemann-pick disease, type C1.

Authors:  Antony Cougnoux; Julia C Yerger; Mason Fellmeth; Jenny Serra-Vinardell; Christopher A Wassif; Niamh X Cawley; Forbes D Porter
Journal:  Mol Genet Metab       Date:  2020-10-18       Impact factor: 4.797

Review 9.  Recent trends in mucopolysaccharidosis research.

Authors:  Hiroshi Kobayashi
Journal:  J Hum Genet       Date:  2018-11-19       Impact factor: 3.172

10.  The ubiquitin-proteasome system and the autophagic-lysosomal system in Alzheimer disease.

Authors:  Yasuo Ihara; Maho Morishima-Kawashima; Ralph Nixon
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.